Extract:
"...The treatment demonstrated a four-fold higher cell expansion at the 600 million dose compared to the 300 million dose, maintaining a manageable safety profile with Grade 3 cytokine release syndrome occurring in only 17% of patients."
https://finance.yahoo.com/news/crispr-therape...35849.html